Zobrazeno 1 - 3
of 3
pro vyhledávání: '"M. P M Q van Gils"'
Autor:
Leo Joskowicz, Moti Freiman, Karl Krissian, Jacob Sosna, Coert Metz, Noy Cohen, Ingrid Sanchez, Julien Mille, T. van Walsum, Wiro J. Niessen, Maciej Orkisz, Wilbur C.K. Wong, M. P M Q van Gils, K. Hameeteman, M. Hernández Hoyos, Gabriel P. Krestin, L. Florez Valencia, L. van den Borne, Olivier Cuisenaire, Michiel Schaap, Mehmet Akif Gulsun, P. Berman, A. van der Lugt, Philippe Douek, Maria A. Zuluaga, Huseyin Tek, M. Aissat, Fethallah Benmansour, S. Rozie, Albert C. S. Chung
Publikováno v:
Medical Image Analysis
Medical Image Analysis, Elsevier, 2011, 15 (4), pp.477-488. ⟨10.1016/j.media.2011.02.004⟩
Medical Image Analysis, 15(4), 477-488. Elsevier
Medical Image Analysis, Elsevier, 2011, 15 (4), pp.477-488. ⟨10.1016/j.media.2011.02.004⟩
Medical Image Analysis, 15(4), 477-488. Elsevier
International audience; This paper describes an evaluation framework that allows a standardized and objective quantitative comparison of carotid artery lumen segmentation and stenosis grading algorithms. We describe the data repository comprising 56
Autor:
O. Nilsson, Freddie C. Hamdy, Kim Pettersson, Chris H. Bangma, Ulf Hakan Stenman, Hans Lilja, Theo M. Luider, Rainer Bischoff, H. Takalo, M. P M Q van Gils, Anders Bjartell, P. F A Mulders, Jack Schalken, Fritz H. Schröder
Publikováno v:
European Urology. 48:1031-1041
An overview is given of serum and urine prostate cancer markers that are currently under investigation and subsequently the P-Mark project is introduced. There are many markers showing promise to overcome the limitations of prostate specific antigen
Autor:
M P M Q, van Gils, U H, Stenman, J A, Schalken, F H, Schröder, T M, Luider, H, Lilja, A, Bjartell, F C, Hamdy, K S I, Pettersson, R, Bischoff, H, Takalo, O, Nilsson, P F A, Mulders, C H, Bangma
Publikováno v:
European urology. 48(6)
An overview is given of serum and urine prostate cancer markers that are currently under investigation and subsequently the P-Mark project is introduced. There are many markers showing promise to overcome the limitations of prostate specific antigen